Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 577
  • Home
  • Print this page
  • Email this page


 
 Table of Contents  
CASE REPORT
Year : 2016  |  Volume : 2  |  Issue : 1  |  Page : 31-33

Amniotic fluid embolism during emergency hysterotomy


Department of Anaesthesiology and Critical Care, Rural Medical College, Pravara Institute of Medical Sciences, Loni, Maharashtra, India

Date of Web Publication16-Sep-2016

Correspondence Address:
Akshaya N Shetti
Department of Anaesthesiology and Critical Care, Rural Medical College, Pravara Institute of Medical Sciences, Loni, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2394-6954.190774

Rights and Permissions
  Abstract 

The most common obstetric surgeries performed in India are cesarean section. Unwillingness to undergo normal delivery, unfavorable anatomy, previous cesarean section, and pregnancy-induced hypertension are common indications to name. Although pregnancy is a natural process, many physiological changes occur in maternal health. Pregnant lady is at risk to develop pregnancy-related complications. Amniotic fluid embolism is one of the life-threatening complications that is seen during delivery.

Keywords: Amniotic fluid, anesthesia, cardiac arrest, cesarean section embolism, pulmonary edema


How to cite this article:
Bhuva A, Shetti AN, Kharde V, Divekar D. Amniotic fluid embolism during emergency hysterotomy. Karnataka Anaesth J 2016;2:31-3

How to cite this URL:
Bhuva A, Shetti AN, Kharde V, Divekar D. Amniotic fluid embolism during emergency hysterotomy. Karnataka Anaesth J [serial online] 2016 [cited 2019 Aug 17];2:31-3. Available from: http://www.karnatakaanaesthj.org/text.asp?2016/2/1/31/190774


  Introduction Top


Entry of amniotic fluid containing fetal cells, hair, bile-stained meconium, and or fetal gut mucin into the maternal circulation is a rare catastrophic obstetric emergency. It may present as a sudden maternal collapse which is commonly associated with hypoxemia, hypotension, pulmonary edema, or coagulopathy. The mode of entry is via ruptured membranes or ruptured uterine or cervical vessels down a pressure gradient. Portal of entry is either placental implantation site or more commonly thought to be through small tears in lower uterine segment or endocervix. For the first time, it was reported by R Meyer in 1926. [1] In 1941, based on clinical and pathological findings, Steiner and Lushbaugh reported amniotic fluid embolism (AFE). [2]

The incidence of AFE ranges between 1 in 8000 and 1 in 80,000 pregnancies, with various estimates between these two extremes. [3] Maternal outcome following AFE is not promising. Maternal mortality ranges from 44% to 61% depending on the severity of disease. [4],[5]

The exact pathophysiology of AFE is unclear, but multiple systems are affected and may be immune-mediated. Risk factors that may contribute for AFE include uterine hyperstimulation, advanced maternal age, multiparity, placenta previa, abruption, eclampsia, uterine rupture, instrumental vaginal delivery, cesarean section, and male neonate.


  Case Report Top


A 20-year-old primigravida with 29 weeks of gestation was referred from a private clinic with moderate pervaginal bleeding and associated with mild abdominal pain. General examination showed evidence of pre-eclampsia. Obstetrician found 250 g of clots on vaginal examination, suspected to be arising from placental abruption resulting in intrauterine death and made a decision for emergency hysterotomy.

On preoperative examination of the patient, we noted pulse rate (PR) of 150/min, blood pressure (BP) of 130/100 mmHg, respiratory rate of 26/min, and presence of pallor and pedal edema. We could not find any systemic abnormality. Laboratory reports revealed hemoglobin 13.9 g%, platelet count 1.53 lakhs/mm 3 , International Normalized Ratio (INR) 1.13, and activated partial thromboplastin time (APTT) 29 s over the control of 30 s and urine albumin 3+. Both renal and liver function tests were within normal range. Placenta previa was ruled out by ultrasound examination.

We did choose general anesthesia in view of better hemodynamic stability. Ringer lactate (RL) infusion was continued through 18 g intravenous catheter. The patient was premedicated with injection diazepam 5 mg and injection fentanyl 40 μg intravenous (IV). Preoxygenation was done for 3 min and induced with titrated dose of injection thiopentone 150 mg when eyelash reflex was abolished. Intubation was facilitated with injection vecuronium 0.8 mg/kg. Anesthesia was maintained with end-tidal concentration of 0.8% isoflurane and nitrous oxide 50% in 50% oxygen. The patient's lungs were mechanically ventilated. Intraoperatively, sufficient analgesia was provided by additional doses of fentanyl with a total dose of 100 mcg. A total of 1250 ml of RL was given during surgery, which lasted for 90 min. Hemodynamic parameters remained stable throughout surgery. Isoflurane was discontinued after the closure of abdomen, and residual neuromuscular block was antagonized with injection neostigmine 0.05 mg/kg and injection glycopyrrolate 0.008 mg/kg. The patient's spontaneous respiration was inadequate, so she was assisted with Bain's circuit with 100% O 2 and vitals were closely monitored. IV calcium gluconate 500 mg was given slowly over 10 min. Arterial blood gas (ABG) was done and it suggested severe metabolic acidosis with pH - 7.04, PO 2 - 72, PCO 2 - 47, HCO 3 - 12.7, and SO 2 - 84%.

Injection sodium bicarbonate 50 ml IV was stat administered and 50 ml in RL was slowly infused. Vitals were PR 130/min, BP 138/88 mmHg, and SpO 2 98% on 100% O 2 with ventilation on Bain's circuit. Her response was inadequate and she developed bubbling crepitation in lungs bilaterally. Pupils were mid-dilated with sluggish reaction to light. Urine output was 25 ml throughout the surgery. The patient was propped up and ventilation continued with Bain's circuit with positive end-expiratory pressure (PEEP). Titrated doses of injection lasix at a total of 80 mg, injection hydrocortisone 100 mg, and injection dexamethasone 8 mg were administered. IV fluid (RL) was continued at 60 ml/h. The patient remained unresponsive. Urine output was nil.

After about 45 min, she suddenly developed bradycardia with heart rate of 30/min, unrecordable BP, and SpO 2 decreased to 60% despite ventilation with 100% O 2 . Immediately, cardiopulmonary resuscitation (CPR) was started with >100 chest compression per minute. Injection adrenaline 1 mg IV was repeated 4 times for every 5 min. CPR was continued. Injection dobutamine infusion at 10 μg/kg/min was started. There was pink frothy fluid on suctioning of endotracheal tube.

After 30 min, electrocardiography showed sinus rhythm with HR 110/min, BP 84/56 mmHg, and SpO 2 96%, but B/L crepitation persisted. ABG showed pH 6.84, PO 2 - 57, PCO 2 - 72, HCO 3 - 12.3, and SO 2 - 59%, despite mechanical ventilation with FiO 2 of 1. Injection sodium bicarbonate 50 ml IV and 50 ml in RL was repeated. Injection dobutamine was titrated and increased to 20 μg/kg/min. Four units of fresh frozen plasma (FFP) were administered.

Postoperative blood investigation revealed Hb 9 g%, platelet count 96,000 cells/mm 3 , INR 1.81, and APTT 70 s over the control of 30 s, serum glutamic-oxaloacetic transaminase 945 and serum glutamic pyruvic transaminase 460.

On examination, PR was 130/min, BP was 104/52 mmHg, and SpO 2 was 94% RS B/L crepts were still present; pupils were mid-dilated, sluggishly reacting to light. The patient was shifted to Intensive Care Unit and continued mechanical ventilation continued with BIPAP mode with PEEP 14 mmHg, but her response was poor. Injection lasix 20 mg IV was repeated but urine output was nil.

After 1 h, again the patient's SpO 2 decreased to <60%, ABG showed pH 7.01, PO 2 - 25, PCO 2 - 47, HCO 3 - 11.9, and SO 2 - 20%. The patient developed sudden cardiac arrest after about 5 h of surgery from which she could not be revived in spite of all resuscitative measures.


  Discussion Top


The classic triad of AFE is sudden cardiovascular collapse, dysponea, and coagulopathy. [6] Profund hypotension and fetal distress occur in almost all cases with pulmonary edema, acute respiratory distress, cyanosis, coagulopathy, and cardiopulmonary arrest occurring in 80-90% cases. Nonspecific symptoms such as nausea, vomiting, chest pain, paresthesia, impending sense of doom, and agitation may be seen waxing and waning up to 4 h before the cardiovascular collapse.

There will be only mild to moderate elevations in pulmonary artery pressures with associated evidence of severe left ventricular (LV) dysfunction. Based on the previous reports, a biphasic model was put forward. It explains the hemodynamic abnormalities that occur with amniotic fluid emboli.

According to this model, the first phase that lasts for about 30 min was due to a anaphylactoid reaction to fetal antigens resulting in the release of biochemical mediators leading to pulmonary vasospasm, pulmonary hypertension, and right ventricular (RV) dysfunction resulting in hypoxia, hypotension, and capillary damage. These biochemical mediators also trigger disseminated intravascular coagulation. In the second phase, it leads to uterine atony and massive hemorrhage. Pulmonary edema and LV failure are pathognomonic of AFE possibly due to myocardial ischemia or direct myocardial depressant effect of AFE is seen during the second phase. [7] Products of fetal tissue are responsible only for minor effect resulting in actual mechanical obstruction. [8]

Diagnosis of AFE is by exclusion criteria depending on clinical presentation rather than on histopathological findings. It is aided by nonspecific and specific diagnostic tests. Nonspecific tests are INR, prothrombin time, APTT, hypoxemia on ABG, RV strain pattern on electrocardiogram, decrease in C 3 -C 4 complement levels, and demonstration of RV or LV dysfunction on ultrasound/transesophageal echocardiography. Diagnostic tests include cytological analysis of central venous blood and broncho-alveolar fluid, Sialyl-Tn antigen test, zinc coproporphyrin concentration, and serum tryptase concentrations,. [9] and more recently, measurement of insulin-like growth factor binding protein. [10]

The key factors in the management are early recognition, oxygenation by intubation and ventilation, intravenous fluids, vasopressor, and inotropes. FFP, cryoprecipitate, platelets, and recombinant factor VII should be considered for consumptive coagulopathy. Other treatment methods tried are inhaled nitric oxide, [11] aerosolized prostacyclin [12] steroids, hemofiltration, [13] cardio-pulmonary bypass, thrombolysis and pulmonary artery thrombectomy, [14] exchange transfusion, [15] and intra-aortic balloon pump. [16]


  Conclusion Top


Although the mortality due to AFE has shown a decline in number, especially in developed countries, it may be due to early re-organization and aggressive management. The pathophysiology of AFE remains an enigma. Although certain risk factors have been identified, AFE cannot be completely prevented.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
  References Top

1.
Meyer JR. Embolia pulmonar amnio-caseosa. Braz Med 1926;2:301-3.  Back to cited text no. 1
    
2.
Steiner PE, Lushbaugh CC. Maternal pulmonary embolism by fluid as a cause of obstetric shock and unexpected deaths in obstetrics. JAMA 1941;117:1245-54.  Back to cited text no. 2
    
3.
Morgan M. Amniotic fluid embolism. Anesthesia 1979;30:20-6.  Back to cited text no. 3
    
4.
Clark SL, Hankins GD, Dudley DA, Dildy GA, Porter TF. Amniotic fluid embolism: Analysis of the national registry. Am J Obstet Gynecol 1995;172 (4 Pt 1):1158-67.  Back to cited text no. 4
    
5.
Tuffnell DJ. United Kingdom amniotic fluid embolism register. BJOG 2005;112:1625-9.  Back to cited text no. 5
    
6.
Vlies R. Amniotic fluid embolism. In: Why Mothers Die 2000-2002, Confidential Enquiry into Maternal and Child Health. London: Royal College of Obstetricians and Gynaecologists; 2004. p. 96-101.  Back to cited text no. 6
    
7.
Clark SL. New concepts of amniotic fluid embolism: A review. Obstet Gynecol Surv 1990;45:360-8.  Back to cited text no. 7
    
8.
Dedhia JD, Mushambi MC. Amniotic fluid embolism. Contin Educ Anaesth Crit Care Pain J 2007;7:152-6.  Back to cited text no. 8
    
9.
Conde-Agudelo A, Romero R. Amniotic fluid embolism: An evidence-based review. Am J Obstet Gynecol 2009;201:445.e1-13.  Back to cited text no. 9
    
10.
Legrand M, Rossignol M, Dreux S, Luton D, Ventré C, Barranger E, et al. Diagnostic accuracy of insulin-like growth factor binding protein-1 for amniotic fluid embolism. Crit Care Med 2012;40:2059-63.  Back to cited text no. 10
    
11.
McDonnell NJ, Chan BO, Frengley RW. Rapid reversal of critical haemodynamic compromise with nitric oxide in a parturient with amniotic fluid embolism. Int J Obstet Anesth 2007;16:269-73.  Back to cited text no. 11
    
12.
Van Heerden PV, Webb SA, Hee G, Corkeron M, Thompson WR. Inhaled aerosolized prostacyclin as a selective pulmonary vasodilator for the treatment of severe hypoxaemia. Anaesth Intensive Care 1996;24:87-90.  Back to cited text no. 12
    
13.
Kaneko Y, Ogihara T, Tajima H, Mochimaru F. Continuous hemodiafiltration for disseminated intravascular coagulation and shock due to amniotic fluid embolism: Report of a dramatic response. Intern Med 2001;40:945-7.  Back to cited text no. 13
    
14.
Esposito RA, Grossi EA, Coppa G, Giangola G, Ferri DP, Angelides EM, et al. Successful treatment of postpartum shock caused by amniotic fluid embolism with cardiopulmonary bypass and pulmonary artery thromboembolectomy. Am J Obstet Gynecol 1990;163:572-4.  Back to cited text no. 14
    
15.
Dodgson J, Martin J, Boswell J, Goodall HB, Smith R. Probable amniotic fluid embolism precipitated by amniocentesis and treated by exchange transfusion. Br Med J (Clin Res Ed) 1987;294:1322-3.  Back to cited text no. 15
    
16.
Hsieh YY, Chang CC, Li PC, Tsai HD, Tsai CH. Successful application of extracorporeal membrane oxygenation and intra-aortic balloon counterpulsation as lifesaving therapy for a patient with amniotic fluid embolism. Am J Obstet Gynecol 2000;183:496-7.  Back to cited text no. 16
    




 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
Abstract
Introduction
Case Report
Discussion
Conclusion
References

 Article Access Statistics
    Viewed1021    
    Printed87    
    Emailed0    
    PDF Downloaded90    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]